Search results
Results from the WOW.Com Content Network
Leptospirosis is treated with the antibiotics doxycycline and penicillin. [28] There are more than 200 diverse pathogenic Leptospira serovars, making it challenging to develop an effective vaccine. [31] However, vaccines for the serovars known as Hardjo, Pomona, Canicola, Grippotyphosa and icterohaemorrhagiae have been developed.
ACIP statements are official federal recommendations for the use of vaccines and immune globulins in the U.S., and are published by the CDC. ACIP reports directly to the CDC director, although its management and support services are provided by CDC's National Center for Immunization and Respiratory Diseases .
Since consensus statements provide a "snapshot in time" of the state of knowledge in a particular topic, they must periodically be re-evaluated and published again, replacing the previous consensus statement. Consensus statements differ from medical guidelines, another form of state-of-the-science public statements. According to the NIH ...
Lymphocytic choriomeningitis (LCM) is a rodent-borne viral infectious disease that presents as aseptic meningitis, encephalitis or meningoencephalitis.Its causative agent is lymphocytic choriomeningitis mammarenavirus (LCMV), a member of the family Arenaviridae.
Leptospirosis is a blood infection caused by the bacterium Leptospira [8] that can infect humans, dogs, rodents and many other wild and domesticated animals. [8] Signs and symptoms can range from none to mild (headaches, muscle pains, and fevers) to severe (bleeding in the lungs or meningitis). [5]
Jacinto Convit García (11 September 1913 – 12 May 2014) was a Venezuelan physician and scientist, known for developing a vaccine to prevent leprosy and his studies to treat cancer. He played a role in founding Venezuela's National Institute of Biomedicine and held many leprosy-related positions.
The resulting vaccine was given to about 2,000 children. [12] Many other vaccines, including those for chicken pox and rubella, are made using cell lines originally derived from fetal tissue from two pregnancies terminated in the 1960s, for reasons unrelated to vaccine development.
Launch of the Coalition for Epidemic Preparedness Innovations, CEPI in 2017 at the World Economic Forum in Davos, Switzerland. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).